@MoleculeDxInc
MoleculeDx, Inc. is a molecular diagnostics company advancing research-driven approaches to cancer detection. Its scientific platform is grounded in more than a decade of peer-reviewed research on cancer-associated fusion genes and fusion transcripts. Through Fusion-detect™ Technology, MoleculeDx focuses on multi-marker molecular analysis and the study of circulating fusion-transcript signals, supporting evidence-based research in hepatocellular carcinoma and other areas of cancer science.
4 Articoli
2 Foto
0 Video
-
HCC Screening Test: Advanced Fusion Transcript Analysis
Discover MoleculeDx, Inc.'s HCC screening test, built on research into cancer-associated fusion transcripts. A multi-marker molecular analysis evaluates circulating signals and supports ongoing research in hepatocellular carcinoma assessment.
For more visit - https://www.moleculedx.com/hcc-screening-test-for-high-risk-patients/
HCC Screening Test: Advanced Fusion Transcript Analysis Discover MoleculeDx, Inc.'s HCC screening test, built on research into cancer-associated fusion transcripts. A multi-marker molecular analysis evaluates circulating signals and supports ongoing research in hepatocellular carcinoma assessment. For more visit - https://www.moleculedx.com/hcc-screening-test-for-high-risk-patients/0 Commenti ·0 condivisioni ·65 Views -
Liver Cancer Screening Blood Test | MoleculeDx, Inc.
Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research.
For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/
Liver Cancer Screening Blood Test | MoleculeDx, Inc. Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research. For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/0 Commenti ·0 condivisioni ·109 Views
Altre storie
